How do cells become cancerous, multiply uncontrollably, and form into tumors? And what role do aberrant embryonic stem cells play? These are big questions explored by medical researchers since the embryonic theory of cancer was first proposed in the 19th century. Now, in an exciting new study adding to the global pool of knowledge about the roots of human cancers, researchers are establishing a clear link between different types of cancers and their embryonic origins. They also identify new concepts that can be considered in future drug discovery projects and used in standard chemotherapeutics in the clinic.
The team first sought to identify drugs that can force human embryonic stems cells to acquire adult tissue specification. They saw that drugs stimulating the formation of the embryonic nervous system were the most effective against brain tumors. Molecules promoting the acquisition of primitive gut features were best at blocking the formation of colon tumors. And drugs pushing embryonic cells toward becoming fetal blood cells were the most effective at killing leukemia.
Dr. Benoit's lab at uOttawa -- which aims to create novel anticancer agents that can target epigenetic features of colorectal cancer stem cells -- developed the capacity to measure the effect of certain drugs on cancerous stems cells within colon tumor samples.